Genetic endocrinology of the metabolic syndrome
Genetic endocrinology of the metabolic syndrome
Cardiovascular disease and mortality risk are significantly increased in people with metabolic syndrome, a cluster of interrelated metabolic disorders including obesity, insulin resistance, glucose intolerance, dyslipidemia and hypertension. A complex interplay between predisposing and protective factors ultimately determines whether an individual will develop this set of disorders or not. Genetic factors are one of the significant contributors that predispose to, or protect against, each component of the metabolic syndrome. As in other complex diseases and traits, such genetic factors are likely to be multiple and interacting, with individual polymorphisms producing only a moderate effect. The identification of genetic variants influencing the metabolic syndrome is of great importance to understanding pathogenesis, identifying groups of individuals with different relative risk, and developing or improving therapies against this cluster of metabolic disorders. This has greatly stimulated both theoretical and applied genetic research in recent years. A range of new analytical tools has been developed for the dissection of complex traits. Applied genetic analyses have identified large numbers of candidate markers and chromosomal regions (more than 600 for obesity, which represents only one of the disorders of this cluster). In this chapter, the authors present a basic overview of the genetic approaches currently used for the identification of candidate genetic factors involved in the metabolic syndrome. The authors also summarise current evidence suggesting that genetic variants within elements of the endocrine system are directly involved in the risk of the metabolic syndrome. The authors focused their attention on endocrine pathways for which candidate genetic variants have been identified, and they introduced the foundations of a new hypothesis which postulates the involvement of a network of endocrine genetic setpoints as a combined contributor to the risk of the metabolic syndrome.
978-1-60692-168-5
Rodríguez, Santiago
c6c96d3c-f050-4e2b-bb6c-2d388b9d031f
Gaunt, Tom R.
ff4bc39d-405c-4ba1-896b-7e7d2f747387
Abdollahi, Mohammad R.
96ec68db-6302-4216-9aaf-9951a44be8b8
Sonnenberg, Sabine
e0ee3f86-a03d-473b-901c-f6259a8f7f83
Da, Ian N.M.
26cbac50-0953-4387-a315-cf1a89e9e814
2009
Rodríguez, Santiago
c6c96d3c-f050-4e2b-bb6c-2d388b9d031f
Gaunt, Tom R.
ff4bc39d-405c-4ba1-896b-7e7d2f747387
Abdollahi, Mohammad R.
96ec68db-6302-4216-9aaf-9951a44be8b8
Sonnenberg, Sabine
e0ee3f86-a03d-473b-901c-f6259a8f7f83
Da, Ian N.M.
26cbac50-0953-4387-a315-cf1a89e9e814
Rodríguez, Santiago, Gaunt, Tom R., Abdollahi, Mohammad R., Sonnenberg, Sabine and Da, Ian N.M.
(2009)
Genetic endocrinology of the metabolic syndrome
(Metabolic Diseases - Laboratory and Clinical Research),
Hauppauge, US.
Nova Science Publishers, 103pp.
Abstract
Cardiovascular disease and mortality risk are significantly increased in people with metabolic syndrome, a cluster of interrelated metabolic disorders including obesity, insulin resistance, glucose intolerance, dyslipidemia and hypertension. A complex interplay between predisposing and protective factors ultimately determines whether an individual will develop this set of disorders or not. Genetic factors are one of the significant contributors that predispose to, or protect against, each component of the metabolic syndrome. As in other complex diseases and traits, such genetic factors are likely to be multiple and interacting, with individual polymorphisms producing only a moderate effect. The identification of genetic variants influencing the metabolic syndrome is of great importance to understanding pathogenesis, identifying groups of individuals with different relative risk, and developing or improving therapies against this cluster of metabolic disorders. This has greatly stimulated both theoretical and applied genetic research in recent years. A range of new analytical tools has been developed for the dissection of complex traits. Applied genetic analyses have identified large numbers of candidate markers and chromosomal regions (more than 600 for obesity, which represents only one of the disorders of this cluster). In this chapter, the authors present a basic overview of the genetic approaches currently used for the identification of candidate genetic factors involved in the metabolic syndrome. The authors also summarise current evidence suggesting that genetic variants within elements of the endocrine system are directly involved in the risk of the metabolic syndrome. The authors focused their attention on endocrine pathways for which candidate genetic variants have been identified, and they introduced the foundations of a new hypothesis which postulates the involvement of a network of endocrine genetic setpoints as a combined contributor to the risk of the metabolic syndrome.
This record has no associated files available for download.
More information
Published date: 2009
Organisations:
Cancer Sciences
Identifiers
Local EPrints ID: 364272
URI: http://eprints.soton.ac.uk/id/eprint/364272
ISBN: 978-1-60692-168-5
PURE UUID: 3a9f6e41-0790-4ccc-b364-60335c38044f
Catalogue record
Date deposited: 25 Apr 2014 15:22
Last modified: 09 Apr 2024 22:35
Export record
Contributors
Author:
Santiago Rodríguez
Author:
Tom R. Gaunt
Author:
Mohammad R. Abdollahi
Author:
Sabine Sonnenberg
Author:
Ian N.M. Da
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics